Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
7 Patents
#7 in Aix-en-Provence
#2,219 in France
Graftys
Forward Citations = 8
9 inventors:
Graftys
EPO Patents = 5
Forward Citations = 8
Loading Chart...
Loading Chart...
9 inventors (with patents filed for the assignee):
Jean-Michel Bouler (7 out of 10 patents)
Bruno Bujoli (6 out of 11 patents)
Pascal Janvier (6 out of 9 patents)
4. Ibrahim Khairoun (5 out of 7 patents)
5. Charlotte Mellier (3 out of 3 patents)
6. Olivier Gauthier (2 out of 2 patents)
7. Jean-Noël Argenson (2 out of 2 patents)
8. Verena Schnitzler (2 out of 3 patents)
9. Pierre Weiss (1 out of 9 patents)
7 patents:
3. 9913928 - Injectable calcium-phosphate cement releasing a bone resorption inhibitor (2018-03-13),
Company Overview
Graftys is a leading biotechnology company specializing in bone regeneration and tissue engineering. With a focus on developing innovative solutions for orthopedic and dental applications, Graftys has established itself as a key player in the field of regenerative medicine. Utilizing cutting-edge technology and a team of experienced researchers, Graftys is dedicated to improving patient outcomes and quality of life through their advanced bone grafting products.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Graftys. Retrieved from https://idiyas.com/company/graftys
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
5 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]